Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
- PMID: 30694309
- PMCID: PMC6439759
- DOI: 10.1001/jama.2018.17847
Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Abstract
This systematic review to support the 2019 US Preventive Services Task Force Reaffirmation Recommendation Statement on ocular prophylaxis for gonococcal ophthalmia neonatorum summarizes published evidence on the benefits and harms of ocular topical medication to prevent gonococcal conjunctival infection in newborns.
Conflict of interest statement
Figures

References
-
- Centers for Disease Control and Prevention (CDC) STDs in women and infants. CDC website. https://www.cdc.gov/std/stats17/womenandinf.htm. Updated July 24, 2018. Accessed November 26, 2018.
-
- Kapoor V, Whyte R, Vedula S. Interventions for preventing ophthalmia neonatorum. Cochrane Database Syst Rev. 2016;(9):CD001862 http://onlinelibrary.wiley.com/doi/001810.001002/14651858.CD14001862.pub.... - PMC - PubMed
-
- U.S. Preventive Services Task Force Ocular prophylaxis for gonococcal ophthalmia neonatorum: reaffirmation recommendation statement. Am Fam Physician. 2012;85(2):195-196. - PubMed
-
- Mabry-Hernandez I, Oliverio-Hoffman R. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Evidence Update for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement. Rockville, MD: Agency for Healthcare Research and Quality; 2010.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical